Managing generalized interferon-induced eruptions and the effectiveness of desensitization: Clinical Allergy

Clinical and Experimental Allergy

Volumn 44, Issue 5, 2014, Pages 756-764

  Poreaux, C ^a   Bronowicki, J P ^b   Debouverie, M ^b   Schmutz, J L ^a   Waton, J ^a   Barbaud, A ^a  

^a CHU NANCY BRABOIS   (France)

^b UNIVERSITY HOSPITAL OF NANCY   (France)

Author keywords

Cutaneous adverse drug reaction; Drug allergy; Interferon; Skin tests; Tolerance induction

Indexed keywords

ALPHA INTERFERON; ANTIHISTAMINIC AGENT; BETA INTERFERON; CORTICOSTEROID; PEGINTERFERON; PEGINTERFERON ALPHA2A; PEGINTERFERON ALPHA2B; TACROLIMUS; BOCEPREVIR; DESLORATADINE; PEGINTERFERON ALPHA; RIBAVIRIN; TELAPREVIR; ANTIVIRUS AGENT; INTERFERON;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CORTICOSTEROID THERAPY; CROSS REACTION; CROSS-SECTIONAL STUDY; DESENSITIZATION; DRUG ERUPTION; FEMALE; HUMAN; IMMUNOLOGICAL TOLERANCE; INTRACUTANEOUS TEST; MALE; MIDDLE AGED; PRIORITY JOURNAL; PROSPECTIVE STUDY; SKIN EXAMINATION; SKIN TEST; VERY ELDERLY; ALLERGY TEST; CHRONIC MYELOID LEUKEMIA; CLINICAL STUDY; CONTROLLED STUDY; DRUG EFFICACY; DRUG TOLERANCE; DRUG WITHDRAWAL; ECZEMA; HEPATITIS C; LICHENOID; MELANOMA; MULTIPLE SCLEROSIS; POLYCYTHEMIA VERA; RETROSPECTIVE STUDY; URTICARIA; VIRUS LOAD; DRUG ERUPTIONS; PATHOLOGY; PROCEDURES; SKIN; TREATMENT OUTCOME;

ADULT; AGED; AGED, 80 AND OVER; ANTIVIRAL AGENTS; CROSS-SECTIONAL STUDIES; DESENSITIZATION, IMMUNOLOGIC; DRUG ERUPTIONS; FEMALE; HUMANS; INTERFERONS; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES; SKIN; TREATMENT OUTCOME;

EID: 84910668864     PISSN: 09547894     EISSN: 13652222     Source Type: Journal    
DOI: 10.1111/cea.12217     Document Type: Article

References (13)

1. Pichler WJ. Adverse side-effects to biological agents. Allergy 2006; 61:912-20.
2. Taghavi SA, Eshraghian A. Successful interferon desensitization in a patient with chronic hepatitis C infection. World J Gastroenterol 2009; 15:4196-8.
3. Castells MC, Tennant NM, Sloane DE et al. Hypersensitivity reactions to chemotherapy: outcomes and safety of rapid desensitization in 413 cases. J Allergy Clin Immunol 2008; 122:574-80.
4. Brockow K, Romano A, Blanca M, Ring J, Pichler W, Demoly P. General considerations for skin test procedures in the diagnosis of drug hypersensitivity. Allergy 2002; 57:45-51.
5. Cernadas JR, Brockow K, Romano A et al. General considerations on rapid desensitization for drug hypersensitivity-a consensus statement. Allergy 2010; 65:1357-66.
6. Rosique-Robles D, Vicent Verge JM, Borrás-Blasco J et al. Successful desensitization protocol for hypersensitivity reactions caused by oxaliplatin. Int J Clin Pharmacol Ther 2007; 45:606-10.
7. Castells M, Sancho-Serra Mdel C, Simarro M. Hypersensitivity to antineoplastic agents: mechanisms and treatment with rapid desensitization. Cancer Immunol Immunother 2012; 61:1575-84.
8. Manjón-Haces JA, Vázquez-López F, Gómez-Díez S et al. Adverse cutaneous reactions to interferon alfa-2b plus ribavirin therapy in patients with chronic hepatitis C virus. Acta Derm Venereol 2001; 81:223.
9. Detmar U, Agathos M, Nerl C. Allergy of delayed type to recombinant interferon alpha 2c. Contact Dermatitis 1989; 20:149-50.
10. Meller S, Erhardt A, Auci A, Neumann NJ, Homey B. Drug-induced exanthema caused by pegylated interferon-alpha 2b. Hautarzt 2003; 54:992-3.
11. Dereure O, Raison-Peyron N, Larrey D, Blanc F, Guilhou J-J. Diffuse inflammatory lesions in patients treated with interferon alfa and ribavirin for hepatitis C: a series of 20 patients. Br J Dermatol 2002; 147:1142-6.
12. Berger L, Descamps V, Marck Y et al. Eczéma induit par l'interféron alpha chez les malades atopiques infectés par le virus de l'hépatite C: 4 observations. Ann Dermatol Venerol 2000; 127:51-5.
13. Brown DL, Login IS, Borish L, Powers PL. An urticarial IgE-mediated reaction to interferon beta-1b. Neurology 2001; 56:1416-7.